CL2008003332A1 - Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma. - Google Patents

Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma.

Info

Publication number
CL2008003332A1
CL2008003332A1 CL2008003332A CL2008003332A CL2008003332A1 CL 2008003332 A1 CL2008003332 A1 CL 2008003332A1 CL 2008003332 A CL2008003332 A CL 2008003332A CL 2008003332 A CL2008003332 A CL 2008003332A CL 2008003332 A1 CL2008003332 A1 CL 2008003332A1
Authority
CL
Chile
Prior art keywords
glaucoma
treatment
compounds derived
acceptable composition
ophthalmologically acceptable
Prior art date
Application number
CL2008003332A
Other languages
English (en)
Inventor
Yariv Donde
Jeremiah H Nguyen
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40524829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003332(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CL2008003332A1 publication Critical patent/CL2008003332A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D333/40—Thiophene-2-carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Abstract

Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; líquido aceptable oftalmológicamente; y uso para el tratamiento del glaucoma.
CL2008003332A 2007-11-09 2008-11-07 Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma. CL2008003332A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98684907P 2007-11-09 2007-11-09
US12/265,062 US9006464B2 (en) 2007-11-09 2008-11-05 Substituted cyclopentanes having prostaglandin activity

Publications (1)

Publication Number Publication Date
CL2008003332A1 true CL2008003332A1 (es) 2011-08-12

Family

ID=40524829

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003332A CL2008003332A1 (es) 2007-11-09 2008-11-07 Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma.

Country Status (21)

Country Link
US (1) US9006464B2 (es)
EP (1) EP2217581B1 (es)
JP (1) JP2011503089A (es)
KR (1) KR20100101097A (es)
CN (2) CN102977048A (es)
AR (1) AR069228A1 (es)
AU (1) AU2008324793B2 (es)
BR (1) BRPI0818902A2 (es)
CA (1) CA2705150C (es)
CL (1) CL2008003332A1 (es)
CO (1) CO6280480A2 (es)
DK (1) DK2217581T3 (es)
ES (1) ES2432058T3 (es)
IL (1) IL205604A (es)
MX (1) MX2010005105A (es)
NZ (1) NZ585517A (es)
RU (1) RU2481339C2 (es)
TW (1) TWI411438B (es)
UA (1) UA99840C2 (es)
WO (1) WO2009061811A1 (es)
ZA (1) ZA201003304B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20100247606A1 (en) * 2009-03-25 2010-09-30 Allergan, Inc. Intraocular sustained release drug delivery systems and methods for treating ocular conditions
EA202290013A1 (ru) 2019-06-28 2022-03-18 Общество С Ограниченной Ответственностью "Регеус" Средство для усиления роста волос

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7012A (en) * 1850-01-15 Improvement in mowing-machines
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
JPS5623984B2 (es) * 1973-04-19 1981-06-03
US4065472A (en) * 1975-09-29 1977-12-27 Pfizer Inc. 5-(2-Carboxythiophen-5-yl)-16-aryloxy-α-tetranor-ω-tetranorprostaglandins
GB1563201A (en) * 1975-11-05 1980-03-19 Shell Int Research Preparation of herbicidally acitve alanine derivatives
US5698598A (en) * 1995-08-04 1997-12-16 Allergan EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6545045B1 (en) * 1998-12-24 2003-04-08 Alcon Manufacturing, Ltd. Prostaglandin E agonists for treatment of glaucoma
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs
US7585895B2 (en) * 2005-12-06 2009-09-08 Allergan, Inc. Therapeutic substituted cyclopentanes
US7427685B2 (en) * 2005-12-06 2008-09-23 Allergan, Inc. Therapeutic substituted cyclopentanes
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
WO2008094958A1 (en) * 2007-02-01 2008-08-07 Allergan, Inc. Thiophene derivatives useful as medicaments for treating ocular hypertension

Also Published As

Publication number Publication date
IL205604A (en) 2014-06-30
IL205604A0 (en) 2010-11-30
US20090124676A1 (en) 2009-05-14
DK2217581T3 (da) 2013-10-21
TWI411438B (zh) 2013-10-11
CA2705150A1 (en) 2009-05-14
AU2008324793B2 (en) 2013-12-05
BRPI0818902A2 (pt) 2015-05-12
EP2217581B1 (en) 2013-07-31
CN102977048A (zh) 2013-03-20
WO2009061811A8 (en) 2009-07-02
AR069228A1 (es) 2010-01-06
AU2008324793A1 (en) 2009-05-14
MX2010005105A (es) 2010-05-27
CO6280480A2 (es) 2011-05-20
KR20100101097A (ko) 2010-09-16
JP2011503089A (ja) 2011-01-27
RU2481339C2 (ru) 2013-05-10
CN101952261A (zh) 2011-01-19
TW200934500A (en) 2009-08-16
CN101952261B (zh) 2013-06-12
ZA201003304B (en) 2014-03-26
EP2217581A1 (en) 2010-08-18
RU2010122681A (ru) 2011-12-20
CA2705150C (en) 2016-06-14
WO2009061811A1 (en) 2009-05-14
US9006464B2 (en) 2015-04-14
UA99840C2 (ru) 2012-10-10
ES2432058T3 (es) 2013-11-29
NZ585517A (en) 2012-08-31

Similar Documents

Publication Publication Date Title
CL2009000448A1 (es) Compuestos derivados de 3-sulfonilamino-n-(1h-pirazolo-[3,4-b]piridin-5il)benzamida; procesos de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento del cancer, tal como sarcoma, carcinoma, adenoma, entre otros.
CL2008003332A1 (es) Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma.
CL2012002771A1 (es) Compuestos derivados de ariletinilo sustituidos, moduladores de los receptores mglur5; proceso de obtencion; composicion farmaceutica; y su uso en el tratamiento o prevencion de la esquizofrenia, enfermedades cognitivas, sindrome de x fragil o el autismo.
EA201071169A1 (ru) ГИДРОКСИМЕТИЛПИРРОЛИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ β3
BRPI0803374A2 (pt) compostos polihidróxi como agentes de extinção de polimerização
UY29184A1 (es) Derivados de sulfonilbencimidazol
SV2005002061A (es) Derivados de piridilo y su uso como antagonistas del receptor mglu5 ref. x-16538
UY32125A (es) Compuestos novedosos como ligandos de receptores de canabinoides
CO6541645A2 (es) Compuestos de indol y su uso farmaceutico
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CR20130409A (es) Novedosos derivados de azabencimidazolcíclico útiles como agentes antidiabéticos
ECSP10010722A (es) Compuestos orgánicos
NO20083630L (no) Nye pyridinderivater
CL2012000921A1 (es) Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes.
ECSP066882A (es) Compuestos de imidazol
EA200970067A1 (ru) Агонисты ep2
AR054786A1 (es) (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1
CL2009000873A1 (es) Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b
CL2009001044A1 (es) Compuestos cristalinos derivados de heterociclos puenteados por un alqueno; utiles en el tratamiento de enfermedades metabolicas, enfermedades circulatorias, enfermedades del snc, entre otras enfermedades.
CU24087B1 (es) Compuestos de carbazol
EA201101148A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
EA201101146A1 (ru) Новые гербициды
TW200942524A (en) Novel aminomethyl benzene derivatives
EA201100920A1 (ru) Новые гербициды